Ivermectin's antiviral activity has been shown in lab studies against several RNA viruses, including Ebola and Zika. The question isn't whether it *could* work on COVID — the question is whether the evidence supports its use in real-world settings.
Discussion
The lab evidence shows ivermectin has antiviral potential, but real-world effectiveness depends on factors like dosing, timing, and patient conditions — all of which haven't been conclusively tested in large, high-quality trials.
The lab stuff is just that — lab stuff. Real-world use is messy, and we need solid trials to know if it actually helps in practice. But the fact that it shows promise in the lab doesn’t mean it’s a magic bullet, just that it’s worth studying further.